An interventional study of Bran and Nopal in Constipation and Diet Modification, sponsored by University of Nottingham. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-17.
Sponsored by University of Nottingham · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 61 studies in Constipation with a site in United Kingdom — 4 open to participants now, 5 under way, none of them phase 3. Constipation · United Kingdom.
Among the 61 studies in Constipation with a site in United Kingdom, this one is the 49th largest by enrollment of the 54 interventional ones that give a count, is one of 7 that started in 2018, is one of 23 with no phase, and was the 34th registered.
1,048 studies on the registry are indexed under Constipation; 161 are open to participants now.
Browse Constipation studies →4 of the 61 studies in Constipation with a site in United Kingdom are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in United Kingdom, United States, Belgium and 5 more countries
Ages 18–75
University of Cambridge · Sites in United Kingdom
Ages 55+ · Healthy volunteers
usMIMA S.L. · Sites in United Kingdom
Ages 18+
University of Nottingham · Sites in United Kingdom
Ages 6+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 99 Constipation studies recruiting now, 32 (32%) set no upper age limit and 52 (53%) stop at 75 or younger; 17 take children under 18; 28 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
61 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 9 · Phase 3 15 · Phase 4 6
First in 1998; this study’s year is marked. 7 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 12 is below the median of 75 across 886 interventional studies indexed under Constipation.
Median enrollment 93 across the 54 interventional studies, 170 across the 7 observational. Of the 50 that completed or were terminated, 16 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
33 of 61 have an industry lead sponsor. The 10 most frequent:
University of Nottingham is the lead sponsor of 465 studies on the registry; 80 are open to participants now.
University of Nottingham has 8 studies filed under Constipation — fewer than ten, so there is no comparison to draw.
2 of the studies in Constipation with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07786116University of CambridgeThe Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions | 2027-06 |
| NCT07545772Eli Lilly and CompanyA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C) | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 61 studies in Constipation with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will compare 3 food products (bran, psyllium and nopal) on intestinal water content measured via MRI.
BACKGROUND AND RATIONALE
The role of dietary fibre in human health is a topic of both debate and research. Interpreting evidence is complicated by changes in the definition of fibre. In the UK the Scientific Advisory Committee for Nutrition has recently proposed a definition of "all carbohydrates that are neither digested nor absorbed in the small intestine and have a degree of polymerisation of three or more monomeric units, plus lignin". They have also called for further research into the physiological effects of fibre of the gastrointestinal (GI) tract.
The Nottingham GI MRI group has been at the forefront of elucidating the effects of poorly digested carbohydrates on gastrointestinal physiology. The investigators have published techniques to measure free water in the small bowel and assessment of the physical form of chyme in the colon using MR relaxometry. This includes the demonstration that fructose ingestion on its own leads to increased free water in the small bowel compared to co-ingestion with glucose.
Bran is often confused with dietary fibre. Although it contains fibre, the term actually refers to the outer husk of seeds and grains. It has been shown to accelerate oro-caecal transit (OCT) with scintigraphy. Bran can also be shown to increase small bowel water content, possibly by mechanical stimulation, one of the most powerful stimuli for small intestinal secretion, which may be a mechanism to prevent blockage. In the past bran's high fibre content led to the hypothesis that its effect derived from holding water in the lumen but a comparison study of 17 different fibres found an inverse relationship between their water-holding properties and effect on faecal weight, with bran holding the least water but inducing the largest weight changes. Rather, weight change appeared to relate to the amount of undigested fibre present in the faeces and the associated changes in bacterial numbers, which account for most of dry stool weight.
In contrast, psyllium husk contains a fibre that binds water effectively. On this basis it has been used as a laxative for thousands of years. In fact, there is little evidence that psyllium accelerates whole gut transit time as might be expected of a laxative. Work within the investigating group has shown that psyllium increases water in both the small bowel and the faeces, leading to softer, looser stool.
Nopal is a Mexican dietary product derived from cactus. It contains a different mix of fibre, 2/3rds of which is insoluble like bran fibre and 1/3rd soluble like psyllium. It is the subject of several health claims. The investigating group has recently been awarded a grant by the Newton Fund, through the Medical Research council, to study its effects on gut function. The aim of the Newton Fund is to stimulate collaborative research with middle-income countries such as Mexico. Part of the project plan is to invite a Mexican radiologist, Dr Alfonso Gil-Valadez, to Nottingham to learn about the MRI techniques used by our group.
TRIAL OBJECTIVES AND PURPOSE
Purpose
The purpose of the study is to gather pilot data on the effect of Nopal on intestinal water content, in comparison to bran and psyllium.
Objective
The primary objective is to gather pilot data on the change from baseline in small bowel water content in healthy volunteers after a meal containing nopal, in comparison to meals containing psyllium or bran.
Secondary Objectives
Secondary objectives will be to gather pilot data on the effects of the fibre-containing meals on the physical form of colonic chyme, colonic volume and breath markers of fermentation.
Hypotheses
The test meals will lead to differences in post-prandial water in the small bowel.
The test meals will lead to differences in the post-prandial volume and physical composition of chyme in the colon.
The test meals will not lead to change in breath markers of fermentation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
test meal including nopal powder
Dietary Supplement: Nopal
test meal including psyllium powder
Dietary Supplement: Psyllium
test meal including bran powder
Dietary Supplement: Bran
Change from the baseline in T1 relaxation time (ms) of the chyme in the ascending colon
measured by MRI
Time frame: baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Change from the baseline in small bowel water content (mL)
measured by MRI
Time frame: baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Change from the baseline in colonic volume in mL
measured by MRI
Time frame: baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Change from the baseline of breath hydrogen and methane (ppm)
measured using GastroCHeck
Time frame: baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Plan to share: No
Ran from Apr 2018 to primary completion in Oct 2018, 5 months.
Of 245 non-industry interventional studies with no phase under Constipation, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's 5 months is below that.
Counting every sponsor, half of 316 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Opuntia ficus-indica leaf · Psyllium